#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	14738	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2097	698.5	1	SNP	n	C1184T	0	.	.	1184	1184	C	1416	1416	C	872	C	811	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	14738	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2097	698.5	0	HET	.	.	.	G1413GA	.	1413	1413	G	1645	1645	G	864	G,GA	642,174	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	14738	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2097	698.5	0	HET	.	.	.	C1525T	.	1525	1525	C	1757	1757	C	732	C,T	540,127	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	14738	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2097	698.5	0	HET	.	.	.	A37T	.	37	37	A	269	269	A	848	A,T	661,122	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26592	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3495	758.3	0	.	n	.	0	T695C	SNP	695	695	T	1025	1025	C	822	C,T	755,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26592	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3495	758.3	0	.	n	.	0	A1638G	SNP	1638	1638	A	1968	1968	G	880	G	825	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26592	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3495	758.3	0	.	n	.	0	T1971C	SNP	1971	1971	T	2301	2301	C	905	C	811	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26592	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3495	758.3	1	SNP	n	A2045G	0	.	.	2045	2045	A	2375	2375	A	849	A	786	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26592	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3495	758.3	1	SNP	n	C2597T	0	.	.	2597	2597	C	2927	2927	C	848	C	792	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26592	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3495	758.3	0	HET	.	.	.	A20C	.	20	20	A	350	350	A	537	A,C	172,334	.	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	1906	folP	855	855	100.0	folP.l6.c30.ctg.1	1537	123.4	1	SNP	p	R229S	1	.	.	685	687	AGC	997	999	AGC	188;190;191	A;G;C	172;172;172	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4864	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3245	149.3	1	SNP	p	S91F	1	.	.	271	273	TTC	507	509	TTC	166;167;168	T;T;C	150;151;152	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4864	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3245	149.3	1	SNP	p	D95G	1	.	.	283	285	GGC	519	521	GGC	160;162;162	G;G;C,T	143;145;146,1	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4864	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3245	149.3	1	SNP	p	G95N	0	.	.	283	285	GGC	519	521	GGC	160;162;162	G;G;C,T	143;145;146,1	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_F_01564	mtrR.WHO_F_01564	1	1	27	1532	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1267	120.2	1	SNP	p	G45D	0	.	.	133	135	GGC	428	430	GGC	202;203;203	G;G;C	186;185;185	mtrR.WHO_F_01564:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	824	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	943	87.0	0	.	n	.	0	.206T	INS	206	206	T	569	569	T	214	T	200	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4950	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2935	167.8	1	SNP	p	D86N	0	.	.	256	258	GAC	613	615	GAC	187;186;185	G;A;C	171;172;172	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4950	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2935	167.8	1	SNP	p	R87W	0	.	.	259	261	CGT	616	618	CGT	186;187;188	C;G;T	174;172;174	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4950	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2935	167.8	1	SNP	p	S87R	1	.	.	259	261	CGT	616	618	CGT	186;187;188	C;G;T	174;172;174	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4950	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2935	167.8	1	SNP	p	R87I	0	.	.	259	261	CGT	616	618	CGT	186;187;188	C;G;T	174;172;174	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4950	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2935	167.8	1	SNP	p	S88P	0	.	.	262	264	TCC	619	621	TCC	186;184;186	T;C;C	176;173;176	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3932	parE	1986	1986	100.0	parE.l15.c17.ctg.1	2425	161.2	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1422	1424	GGC	178;177;177	G;G;C	167;165;164	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	3710	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2327	158.3	1	SNP	p	A311V	0	.	.	931	933	GCA	1250	1252	GCA	205;202;200	G;C;A	187;184;184	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3710	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2327	158.3	1	SNP	p	I312M	0	.	.	934	936	ATC	1253	1255	ATC	203;204;205	A;T;C	185;185;186	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3710	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2327	158.3	1	SNP	p	V316P	0	.	.	946	948	GTG	1265	1267	GTG	205;204;205	G;T;G	188;182;182	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3710	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2327	158.3	1	SNP	p	V316T	0	.	.	946	948	GTG	1265	1267	GTG	205;204;205	G;T;G	188;182;182	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3710	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2327	158.3	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1769	1771	ACC	187;185;187	A;C;C	167;168;171	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3710	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2327	158.3	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1823	1825	GCG	203;202;199	G;C,G;G	171;157,1;154	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3710	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2327	158.3	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1823	1825	GCG	203;202;199	G;C,G;G	171;157,1;154	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3710	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2327	158.3	1	SNP	p	G543S	1	.	.	1627	1629	AGC	1946	1948	AGC	172;170;170	A;G;C	158;156;156	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3710	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2327	158.3	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1955	1957	GGC	169;171;172	G;G;C	156;154;155	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3710	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2327	158.3	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1973	1975	CCG	155;158;161	C,CG;C;G	113,1;116;120	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5402	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3111	173.1	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1624	1626	CCG	190;190;188	C;C;G,A	165;174;166,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2066	porA	1146	1146	99.91	porA.l6.c4.ctg.1	2048	100.2	0	.	p	.	0	M83fs	FSHIFT	247	247	A	825	825	C	138	C	126	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2954	porB1b	1047	1047	98.95	porB1b.l15.c17.ctg.1	1421	206.2	0	.	p	.	0	K143Q	NONSYN	427	429	AAA	656	658	CAA	257;258;256	C,T;A;A	235,1;238;236	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2954	porB1b	1047	1047	98.95	porB1b.l15.c17.ctg.1	1421	206.2	0	.	p	.	0	E212S	NONSYN	634	636	GAA	863	865	AGT	222;219;224	A,G;G,A;T	208,1;206,1;206	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2954	porB1b	1047	1047	98.95	porB1b.l15.c17.ctg.1	1421	206.2	0	.	p	.	0	H213D	NONSYN	637	639	CAT	866	868	GAT	226;224;223	G,A;A,G;T	210,1;208,1;207	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2954	porB1b	1047	1047	98.95	porB1b.l15.c17.ctg.1	1421	206.2	0	.	p	.	0	V215A	NONSYN	643	645	GTT	872	874	GCT	216;216;217	G,T;C,A;T	197,1;198,1;199	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2954	porB1b	1047	1047	98.95	porB1b.l15.c17.ctg.1	1421	206.2	0	.	p	.	0	I218M	NONSYN	652	654	ATC	881	883	ATG	210;208;209	A;T;G,C,A	197;194;191,1,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2954	porB1b	1047	1047	98.95	porB1b.l15.c17.ctg.1	1421	206.2	0	.	p	.	0	R257K	NONSYN	769	771	AGG	998	1000	AAG	235;236;241	A,T;A,G;G,T	216,1;216,1;219,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2954	porB1b	1047	1047	98.95	porB1b.l15.c17.ctg.1	1421	206.2	1	SNP	p	G120K	0	.	.	358	360	GGC	587	589	GGC	231;230;230	G;G;C	222;219;221	porB1b.WHO_P_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10924	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4921	221.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1184	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1035	113.7	1	SNP	p	V57M	1	.	.	169	171	ATG	533	535	ATG	239;240;238	A;T;G	221;220;220	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
